Myostatin Is Elevated in Congenital Heart Disease and After Mechanical Unloading
Abstract
Background: Myostatin is a negative regulator of skeletal muscle mass whose activity is upregulated in adult heart failure (HF); however, its role in congenital heart disease (CHD) is unknown.Methods: We studied myostatin and IGF-1 expression via Western blot in cardiac tissue at varying degrees of myocardial dysfunction and after biventricular support in CHD by collecting myocardial biopsies from four patient cohorts: A) adult subjects with no known cardiopulmonary disease (left ventricle, LV), (Adult Normal), (n = 5); B) pediatric subjects undergoing congenital cardiac surgery with normal RV size and function (right ventricular outflow tract, RVOT), (n = 3); C) pediatric subjects with worsening but hemodynamically stable LV failure [LV and right ventricle (LV, RV,)] with biopsy collected at the time of orthotopic heart transplant (OHT), (n = 7); and D) pediatric subjects with decompensated bi-ventricular failure on BiVAD support with biopsy collected at OHT (LV, RV, BiVAD), (n = 3).
Results: The duration of HF was longest in OHT patients compared to BIVAD. The duration of BiVAD support was 4.361.9 days. Myostatin expression was significantly increased in LV-OHT compared to RV-OHT and RVOT, and was increased more than double in decompensated biventricular HF (BiVAD) compared to both OHT and RVOT. An increased myostatin/IGF-1 ratio was associated with ventricular dysfunction.
Conclusions: Myostatin expression in increased in CHD, and the myostatin/IGF-1 ratio increases as ventricular function deteriorates. Future investigation is necessary to determine if restoration of the physiologic myostatin/IGF-1 ratio has therapeutic potential in HF.
Citation
PLoS One. 2011 Sep 13; 6(9):e23818ae974a485f413a2113503eed53cd6c53
10.1371/journal.pone.0023818
Scopus Count
Related articles
- Biventricular assist device-induced right ventricular reverse structural and functional remodeling.
- Authors: Klotz S, Naka Y, Oz MC, Burkhoff D
- Issue date: 2005 Sep
- Myostatin and insulin-like growth factor-1 in hypertensive heart disease: a prospective study in human heart donors.
- Authors: Fernández-Solà J, Borrisser-Pairó F, Antúnez E, Tobías E
- Issue date: 2015 Apr
- Myostatin activation in patients with advanced heart failure and after mechanical unloading.
- Authors: George I, Bish LT, Kamalakkannan G, Petrilli CM, Oz MC, Naka Y, Sweeney HL, Maybaum S
- Issue date: 2010 May
- Outcomes of children with congenital heart disease implanted with ventricular assist devices: An analysis of the Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs).
- Authors: Peng DM, Koehl DA, Cantor RS, McMillan KN, Barnes AP, McConnell PI, Jordan J, Andersen ND, St Louis JD, Maeda K, Kirklin JK, Kindel SJ
- Issue date: 2019 Apr
- Myostatin and IGF-I signaling in end-stage human heart failure: a qRT-PCR study.
- Authors: Baán JA, Varga ZV, Leszek P, Kuśmierczyk M, Baranyai T, Dux L, Ferdinandy P, Braun T, Mendler L
- Issue date: 2015 Jan 16